Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 451,486 |
|
|||||
| News | - | ||||||
| Day High | 4.44 | Low High |
|||||
| Day Low | 3.68 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eliem Therapeutics Inc | ELYM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.48 | -11.48% | 3.70 | 18:05:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.18 | 3.68 | 4.44 | 3.85 | 4.18 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,598 | 451,486 | $ 3.95 | $ 1,785,222 | - | 2.34 - 5.19 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:11:43 | 5 | $ 3.71 | USD |
Eliem Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 106.15M | 27.57M | - | 0 | -35.12M | -1.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eliem Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELYM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.33 | 5.19 | 3.68 | 4.48 | 550,021 | -0.63 | -14.55% |
| 1 Month | 2.92 | 5.19 | 2.52 | 4.55 | 2,223,197 | 0.78 | 26.71% |
| 3 Months | 2.90 | 5.19 | 2.52 | 4.54 | 732,547 | 0.80 | 27.59% |
| 6 Months | 2.59 | 5.19 | 2.35 | 4.51 | 346,088 | 1.11 | 42.86% |
| 1 Year | 3.22 | 5.19 | 2.34 | 4.41 | 183,570 | 0.48 | 14.91% |
| 3 Years | 16.25 | 29.69 | 2.21 | 6.91 | 119,251 | -12.55 | -77.23% |
| 5 Years | 16.25 | 29.69 | 2.21 | 6.91 | 119,251 | -12.55 | -77.23% |
Eliem Therapeutics Description
| Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. |
